OdySight
Commercial- Indications
- Age-related macular degeneration, Diabetic retinopathy, Chronic maculopathies
Company intelligence / Profile preview
Tilak Healthcare has demonstrated positive clinical results with its TIL002 study validating the reliability of the OdySight app for home-based visual acuity monitoring in patients with retinal diseases. The solution enables remote patient management and supports treatment optimization by ophthalmologists based on real-time data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tilak Healthcare.